This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Context. UCB7362(UCB Biopharma) is an oral plasmepsin X (PMX) inhibitor being developed as an antimalarial agent. Malaria is a protozoan…
molecule
2 months ago ●
5 mins read
As biotech experts, risk taking is part of our business model. Without scientific and business risk, inventions would not occur…
Article
6 months ago ●
8 mins read
Context. BAY-069 (Bayer) is a branched-chain amino acid transaminase (BCAT) 1/2 inhibitor. Involved in the synthesis and breakdown of branched-chain…
molecule
2 months ago ●
4 mins read
In this guest article, Dr. LuÃza Cruz breaks down the synthesis of Gilead’s lenacapavir (GS-6207), Drug Hunter’s Small Molecule of…
Article
6 months ago ●
5 mins read
Context. Ziftomenib (KO-539; MD Anderson) is an oral menin inhibitor being developed for mixed-lineage leukemia 1 (MLL1)-rearranged or NPM1-mutated acute…
molecule
3 months ago ●
5 mins read
Readers have been asking for more molecules, so we started a new feature that highlights a few of the molecules…
Article
6 months ago ●
7 mins read
Load More
